Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Inventory (2016 - 2025)

Historic Inventory for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $1.9 billion.

  • Chemours' Inventory rose 3403.07% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 3403.07%. This contributed to the annual value of $1.8 billion for FY2024, which is 3632.32% up from last year.
  • Per Chemours' latest filing, its Inventory stood at $1.9 billion for Q3 2025, which was up 3403.07% from $1.9 billion recorded in Q2 2025.
  • Chemours' Inventory's 5-year high stood at $1.9 billion during Q2 2025, with a 5-year trough of $1.2 billion in Q1 2021.
  • Moreover, its 5-year median value for Inventory was $1.5 billion (2022), whereas its average is $1.6 billion.
  • Per our database at Business Quant, Chemours' Inventory plummeted by 2556.51% in 2024 and then soared by 4208.98% in 2025.
  • Quarter analysis of 5 years shows Chemours' Inventory stood at $1.4 billion in 2021, then grew by 29.98% to $1.8 billion in 2022, then decreased by 24.3% to $1.3 billion in 2023, then skyrocketed by 36.32% to $1.8 billion in 2024, then rose by 4.51% to $1.9 billion in 2025.
  • Its Inventory was $1.9 billion in Q3 2025, compared to $1.9 billion in Q2 2025 and $1.9 billion in Q1 2025.